Teva recalls US-made drugs following contamination fears - The Boston Globe
Teva Pharmaceutical Is in Recovery - WSJ
Teva Pharmaceuticals found to be responsible for its role in the opioid epidemic in New York State - CNN
Teva enters opioid settlement agreement with US state Rhode Island
Teva Pharmaceuticals CEO on the Covid-19 vaccine rollout in Israel - YouTube
Here's Why Teva Pharma Stock Is Soaring Today
Israeli pharma giant Teva reports shrinking profits amid U.S. opioid litigation - U.S. News - Haaretz.com
TEVA Stock News Today | Why did Teva Pharmaceutical Industries stock go down today?
Teva Pharmaceuticals - News, Articles etc. - European Pharmaceutical Review
/cloudfront-us-east-1.images.arcpublishing.com/gray/5ORNVHIZ6FHUHL74IGLVZ6RU4Q.jpg "New York jury holds drug firm Teva liable in opioid crisis")
New York jury holds drug firm Teva liable in opioid crisis
Teva Pharm expects U.S. opioid case settlements to cost $2.6 bln | Reuters
Teva Pharmaceuticals found liable in New York opioid trial - BBC News
US states sue Teva for price-fixing in 'multi-billion dollar fraud' | The Times of Israel
Teva Pharmaceutical Industries (TEVA) Stock Price, News & Info | The Motley Fool
Buy Teva Pharmaceuticals amid positive news, Bernstein says
Teva Pharmaceutical Industries' new CEO Jeremy Levin speaks during a news conference in Tel Aviv May 9, 2012. Teva Pharmaceutical Industries posted a 40 percent jump in quarterly profit that beat estimates,
Teva Pharmaceutical (TEVA) bets on market reopening to regain momentum | AlphaStreet
Teva Pharmaceutical Stock Could Double | Barron's
Teva Pharmaceuticals Q4 2016 Earnings
Teva Pharmaceuticals: Israeli drugmaker to cut 14,000 jobs - BBC News
Suffering from missteps, drugmaker Teva struggles to heal own ills | The Times of Israel
Teva Pharmaceuticals is found liable in the opioid crisis : NPR
Israeli drugmaker Teva to cut quarter of global work force (Update)
A Drug Company Wagers the U.S. Won't Dare Charge It With Crimes - The New York Times
Analysis: Teva Pharmaceuticals is bogged down by legal issues, fails to kick-start growth | Ctech
